26 February 2020

For many types of cancer, surgical resection is the best or only chance for cure. Incomplete excision of tumor tissue however, negatively affects the prognosis of the patient. In many cases, the presence of (microscopic) residual tumor tissue at the resection margins is a direct predictor of patient survival.

The completeness of tumor removal during surgery is dependent on the surgeon’s ability to differentiate tumor from normal tissue. Ideally, surgeons could use real-time information to detect tumors or positive resection margins during surgery. To accomplish radical excision of tumor tissue, radiotracers can be used that target tumor tissue and can be detected using a gamma probe during surgery. Yet, this technique cannot provide a precise delineation of the tumor and resection margins. The addition of a fluorescent label could help to overcome this limitation. Intraoperative fluorescence imaging could allow accurate real-time tumor delineation, but the penetration depth of emitted light in biological tissue is limited. So, a powerful synergy can be achieved by combining radiotracers for the detection of tumor tissue, and fluorescent tracers for subsequent accurate delineation of tumors.

Mark Rijpkema and colleagues are working on the development of new dual-labeled tracers and currently are implementing this into the clinic. For example, in patients with renal cell carcinoma, intraoperative dual-modality imaging is applied using girentuximab labeled with 111In and IRDye800CW. Similarly, in patients with peritoneal metastases of colorectal cancer we have started a study on radiodetection and fluorescence imaging during surgical resection.
The initial results show that both radionuclide detection and fluorescence imaging provide useful information to improve localization of tumors and radical excision of tumor tissue.
 

Related news items


Radboudumc research most lungs recover well after COVID-19

26 November 2020

In severe COVID-19 patients the lung tissue recovers well in most cases. This is shown in research by the Radboudumc, published in Clinical Infectious Diseases. Striking conclusion: patients who were referred by the general practitioner recover worse than ICU patients.

read more

Marianne Boenink has been appointed professor in Ethics of Healthcare

26 November 2020

Health scientist and philosopher Marianne Boenink has been appointed professor in Ethics of Healthcare at the Radboud University/ Radboudumc, as of 1 August 2020.

read more

The effects of the COVID-19 pandemic on (future) parents and their babies

26 November 2020

While the corona crisis affects all of us, people who have just started a family or are trying to, are doing this in a sub-optimal situation. Researchers are trying to find out how the ongoing crisis is affecting them.

read more

Patrick Jeurissen member Scientific Advisory Board for European Commission on health care policy in pandemics

26 November 2020

Patrick Jeurissen, Professor of Affordability of Care, has been appointed as a member of the Scientific Advisory Board for the Pan-European Commission on Health and Sustainable Development. This committee will study healthcare policy in the light of pandemics in the coming year.

read more

Erik van der Heijden received The Distinguished WABIP Regent Award

26 November 2020

The 21st World Conference on Bronchoscopy and Intervention Pulmonology (WCBIP) is currently taking place in Shanghai. This is organized by the WABIP. Erik van der Heijden, member of the scientific organizing committee, received the prize ‘The Distinguished WABIP Regent Award'.

read more

COVID-19 and the kidney overview of papers

26 November 2020

Within the research theme Renal Disorders several studies were initiated to contribute to the knowledge on COVID-19. Check out our overview of the papers that originated from these studies.

read more